Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Advanced breast cancer: diagnosis and treatment

Clinical guideline
Reference number: CG81
Published: 23 February 2009
Last updated: 19 February 2025

Register as a stakeholder

History

Surveillance consultation

Surveillance consultation
Comments form (MSWord 27 KB)

Published:

20 October 2017
Surveillance review proposal (PDF 838 KB)

Published:

20 October 2017

Stakeholder list updated

Stakeholder list (PDF 48 KB)

Published:

17 October 2017

Consultation comments published

Consultation comments and responses (PDF 393 KB)

Published:

16 August 2017

Equality and health inequalities assessment

Equality impact assessment (PDF 277 KB)

Published:

16 August 2017

Addendum consultation

Addendum consultation
Addendum (PDF 4.86 MB)

Published:

11 May 2017
Short version of addendum (PDF 435 KB)

Published:

11 May 2017
Key research recommendations (MSWord 27 KB)

Published:

11 May 2017
Equality impact assessment (PDF 255 KB)

Published:

11 May 2017
Comments form (MSWord 62 KB)

Published:

11 May 2017
Equality impact assessment (PDF 255 KB)

Published:

19 July 2017

Equality and health inequalities assessment

Equality impact assessment (PDF 193 KB)

Published:

18 July 2017

Committee meetings

Committee meeting
Minutes (PDF 250 KB)

Published:

27 March 2017
Minutes 24.03.2017 (PDF 274 KB)

Published:

29 August 2017

Committee list updated

Committee member list (PDF 4.4 KB)

Published:

27 September 2016

Review questions document published

Review questions (PDF 180 KB)

Published:

27 September 2016

Original development on 01 February 2009

Review documents
Breast cancer (advanced): review proposal consultation information
Breast cancer (advanced): consultation document (PDF 577 KB)

Published:

13 February 2012
Breast cancer (advanced): list of stakeholders (PDF 21 KB)

Published:

13 February 2012
CG81 Advanced breast cancer: review decision (PDF 234 KB)

Published:

23 April 2012
CG81 Advanced breast cancer: rapid update - scoping document (PDF 36 KB)

Published:

05 September 2013
Background information
New NICE guidelines on the treatment and care of people with advanced breast cancer (PDF 33 KB)

Published:

06 December 2013
Original development documents 2006 - 2009
Original development documents 2006 - 2009 information
Breast cancer (advanced): stakeholder comments and developer responses (PDF 831 KB)

Published:

25 February 2009
Breast cancer (advanced): final scope (PDF 52 KB)

Published:

22 January 2009
Breast cancer (advanced): consultation on the draft guidance information
Full version (PDF 1.29 MB)

Published:

13 August 2008
NICE version (PDF 226 KB)

Published:

13 August 2008
Evidence review (PDF 2.86 MB)

Published:

13 August 2008
Needs assessment (PDF 364 KB)

Published:

13 August 2008
Comments proforma (MSWord 56 KB)

Published:

13 August 2008
Breast cancer (advanced): list of stakeholders (PDF 21 KB)

Published:

13 February 2012
Breast cancer (advanced): list of Guidance Development Group members (PDF 11 KB)

Published:

10 June 2008
Breast cancer (advanced): GDG minutes
Advanced breast cancer: GDG minutes 02 July 2008 (PDF 22 KB)

Published:

19 November 2008
Advanced breast cancer: GDG minutes 11 April 2008 (PDF 25 KB)

Published:

20 June 2008
Advanced breast cancer: GDG minutes 19 February 2008 (PDF 23 KB)

Published:

29 April 2008
Advanced breast cancer: GDG minutes 22 November 2007 (PDF 22 KB)

Published:

26 February 2008
The guideline development process - an overview for stakeholders, the public and the NHS (third edition) information
The guideline development process - an overview for stakeholders, the public and the NHS (third edition) (PDF 174 KB)

Published:

25 April 2007
Review decision: reviews of TA guidance 34, 54 & 62 information
Remit: Breast cancer (advanced) (PDF 68 KB)

Published:

23 December 2003
Equality impact assessment
Equality impact assessment (PDF 228 KB)

Published:

01 July 2014
Addendum consultation comments
Addendum consultation comments (PDF 421 KB)

Published:

01 July 2014
Advanced Breast Cancer: Addendum consultation
Advanced Breast Cancer: Addendum consultation information
Advanced Breast Cancer: Addendum (PDF 1.6 MB)

Published:

11 March 2014
ABC (SC update): stakeholder list (PDF 105 KB)

Published:

07 March 2014
Final scope
Scope (PDF 206 KB)

Published:

27 February 2014
ABC: Standing Committee Development
ABC: Standing Committee Development
ABC (SC update): stakeholder list (PDF 105 KB)

Published:

07 March 2014
Advanced Breast Cancer: Minutes for Standing Committee A Meeting 1 - 9 & 10 October 2013 (PDF 31 KB)

Published:

11 February 2014
Advanced Breast Cancer: Minutes for Standing Committee A Meeting 2 - 15 January 2014 (PDF 88 KB)

Published:

06 May 2014
Standing committee A - members
Standing committee A - members (PDF 206 KB)

Published:

19 February 2014
Topic expert committee members
Topic expert committee members (PDF 9 KB)

Published:

12 December 2013